ENGLISH: Patient information Vorasidenib

Voranigo® (Vorasidenib) – Patient & Physician Guide (Digital Download)

Price: €0.99

A clear, brief/compact and practical overview of Voranigo® (vorasidenib) — the first targeted tablet therapy for IDH-mutant WHO grade 2 gliomas (astrocytoma & oligodendroglioma).

Perfect for patients, families, general practitioners, neurologists, and oncology teams.

🔹 What’s inside (4 pages):

• How Voranigo works (IDH inhibition & 2-HG reduction)
• Who is eligible (label-based criteria)
• How to take the medication safely
• Benefits from the pivotal INDIGO trial
• Side effects, monitoring schedule & warning signs
• Pregnancy & fertility guidance
• Key drug interactions (clinician-friendly)
• What patients must know at a glance

🔹 Why this guide?

Because the official 30-page EMA document is overwhelming.

This PDF summarizes all essential medical facts in a safe, readable, and evidence-based format — ideal for counselling sessions, patient education, and outpatient practice.

📄 Format: PDF, easy to print or share

📅 Updated: November 2025